Press Releases

Date Title and Summary View
Toggle Summary Oxford Immunotec Announces Appointment of President – North America and Filing for FDA Approval for T-SPOT®.TB
Oxford Immunotec Announces Appointment of President – North America and Filing for FDA Approval for T-SPOT ® .TB Oxford, UK; 19th March 2007 - Oxford Immunotec Ltd, the T cell measurement company, today announces that: it has appointed Jeff Schroeder as President of its North American
View HTML
Toggle Summary Study Results Support Use of T-SPOT®.TB to Monitor Latent TB Infection
Study Results Support Use of T-SPOT ® .TB to Monitor Latent TB Infection Oxford, UK; 5th March 2007 - Oxford Immunotec Ltd, the T cell measurement company, today announced the publication of a recent study demonstrating the potential use of T-SPOT.
View HTML
Toggle Summary Study Results Confirm Superior Performance of Oxford Immunotec Ltd's T-SPOT®.TB Over Other Diagnostic Tests for Tuberculosis
Study Results Confirm Superior Performance of Oxford Immunotec Ltd's T-SPOT ® .TB Over Other Diagnostic Tests for Tuberculosis Oxford, UK; 02 August 2006 - Oxford Immunotec Ltd, the T cell measurement company, has today announced the outcome of two studies comparing its T-SPOT.
View HTML
Toggle Summary Oxford Immunotec Strengthens Team with Two Strategic Board Appointments
Oxford Immunotec Strengthens Team with Two Strategic Board Appointments Oxford, UK; 26 July 2006 - Oxford Immunotec Ltd, the T cell measurement company, has today announced the strengthening of the Board of Directors with two new appointments adding significant strategic and commercial weight.
View HTML
Toggle Summary Oxford Immunotec Sponsors Doctors.net.uk and Masterclass Plus Healthcare Training Programmes to Support Best Practice Guidelines for the Diagnosis of TB
Oxford Immunotec Sponsors Doctors.net.uk and Masterclass Plus Healthcare Training Programmes to Support Best Practice Guidelines for the Diagnosis of TB Oxford, UK; 26 June 2006 - Oxford Immunotec Ltd, the T cell measurement company, has today announced that it is sponsoring two training programmes
View HTML
Toggle Summary Study Results Confirm Ability Of T-SPOT®.TB to Detect Tuberculosis Disease in HIV Infected Patients
Study Results Confirm Ability Of T-SPOT ® .TB to Detect Tuberculosis Disease in HIV Infected Patients Oxford, UK; 05 April 2006 - Oxford Immunotec Ltd, the T cell measurement company, has today announced the outcome of a recent study performed at the Chelsea and Westminster Hospital, London.
View HTML
Toggle Summary Study Results Confirm Maintained Performance of T-SPOT®.TB in Repeat Testing Environment
Study Results Confirm Maintained Performance of T-SPOT ® .TB in Repeat Testing Environment Oxford, UK; 29 March 2006 - Oxford Immunotec Ltd, the T cell measurement company, has today announced the outcome of a recent study, which confirmed that the Company's T-SPOT.
View HTML
Toggle Summary Study Results Confirm Higher Sensitivity of T-SPOT®.TB in Immunosuppressed Patient Groups
Study Results Confirm Higher Sensitivity of T-SPOT ® .TB in Immunosuppressed Patient Groups Oxford, UK; 15 March 2006 - Oxford Immunotec Ltd, the T cell measurement company has today announced the outcome of a recent study completed by a group in Milan demonstrating the sensitivity of T-SPOT.
View HTML
Toggle Summary Oxford Immunotec Announces Further Strengthening of Senior Management Team
Oxford Immunotec Announces Further Strengthening of Senior Management Team Oxford, UK; 27 February 2006 - Oxford Immunotec Ltd, the T cell measurement company, has announced a number of appointments to its Senior Management Team. Philip Page has been appointed as Director, Operations with effect
View HTML
Toggle Summary Oxford Immunotec's T-SPOT®.TB is First Test to Demonstrate Accurate Diagnosis of Latent TB in HIV Patients
Oxford Immunotec's T-SPOT ® .TB is First Test to Demonstrate Accurate Diagnosis of Latent TB in HIV Patients Oxford, UK; 6 February 2006 - Oxford Immunotec Ltd, the Company that monitors T cells for the diagnosis and treatment of disease, today announced the results of a study published
View HTML